Showing results (1-10 of 317) with videos related to
Sort By:
Pageof 32
Immunology Today|November 1, 1993
Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsG ParmianiEuropean Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Future perspectives in specific immunotherapy of melanomaG ParmianiImmunology Today|April 1, 1990
An explanation of the variable clinical response to interleukin 2 and LAK cellsG ParmianiThe Keio Journal of Medicine|July 14, 2001
Melanoma antigens and their recognition by T cellsG ParmianiEuropean Journal of Immunology|May 16, 1998
Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patientsC Castelli, A Mazzocchi, F Rini, et al.Journal of the National Cancer Institute|November 1, 1975
Nonimmunogenic sarcomas induced by 3-methylcholanthrene treatment of murine fibroblasts in diffusion chambersG Carbone, G ParmianiInternational Journal of Cancer|November 15, 1975
Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studiesG Parmiani, G InvernizziTumori|September 1, 1976
Syngeneic antitumor and antiembryo immunization affecting pregnancy in miceR Lembo, G ParmianiTumori|February 28, 1987
Growth inhibition of murine colonic adenocarcinoma by tumor immune but not by IL-2-activated or alloactivated lymphocytesM Rodolfo, G ParmianiCurrent Opinion in Oncology|December 1, 1991
Biologic agents as modifiers of chemotherapeutic effectsG Parmiani, L RivoltiniPageof 32